Inflammation is the immune system’s response to injury or infection: blood vessels dilate, white blood cells flood the area, cytokines signal the body to produce more immune cells, and the tissue repairs itself. In its acute form, a swollen ankle, a fever, inflammation is essential and protective.

Chronic inflammation is different. When the inflammatory response runs at low levels continuously, without a specific injury to resolve, it damages tissues over time. Chronic inflammation is now understood to be central to the pathophysiology of heart disease, type 2 diabetes, Alzheimer’s disease, and several cancers. The question of what drives chronic inflammation in modern populations has made diet, particularly sugar consumption, a significant area of research.

Biomarkers

Inflammation is measured through blood biomarkers, the most commonly studied being:

C-reactive protein (CRP): Produced by the liver in response to inflammatory cytokines, particularly interleukin-6 (IL-6). High-sensitivity CRP (hs-CRP) can detect low levels of systemic inflammation. A reading above 3 mg/L is associated with elevated cardiovascular risk. CRP is the most widely used inflammatory biomarker in research and clinical settings.

Interleukin-6 (IL-6): A cytokine that stimulates CRP production and is involved in immune cell activation, fever production, and a range of inflammatory responses. Chronically elevated IL-6 is associated with insulin resistance and type 2 diabetes.

Tumor necrosis factor-alpha (TNF-α): A cytokine involved in systemic inflammation, produced by macrophages and T-cells. Elevated in obese individuals and in conditions associated with metabolic disease.

Adiponectin: An anti-inflammatory adipokine produced by fat cells. Counterintuitively, adiponectin levels are lower in obese individuals and in the presence of insulin resistance. Higher adiponectin is associated with better metabolic health.

How Sugar Drives Inflammation

Several mechanisms link high sugar consumption to elevated inflammatory markers:

Advanced glycation end products (AGEs). When glucose attaches to proteins or lipids without enzymatic assistance (a process called glycation) the result is an advanced glycation end product. Blood glucose interacts with proteins over time this way, particularly when blood glucose is chronically elevated. AGEs accumulate in tissues, impair their function, and activate receptors (RAGE, receptor for advanced glycation end products) that trigger inflammatory signaling. Glycated hemoglobin (HbA1c). The standard test for long-term blood glucose control, is the most familiar AGE in clinical medicine.

Fructose and uric acid. Fructose metabolism in the liver produces uric acid as a byproduct. Uric acid triggers NLRP3 inflammasome activation. A protein complex in immune cells that produces IL-1β and IL-18, potent pro-inflammatory cytokines. This is the mechanism behind gout (uric acid crystals in joints cause intense inflammation) and may be a contributing mechanism for the vascular inflammation associated with high fructose intake.

Gut microbiome disruption. High sugar diets alter the composition of the gut microbiota. The trillions of bacteria in the digestive tract. Specifically, they tend to increase Proteobacteria and decrease Firmicutes and Bacteroidetes. Some Proteobacteria produce lipopolysaccharide (LPS), an endotoxin that triggers a strong inflammatory response when it crosses the gut lining into the bloodstream. This “metabolic endotoxemia” — the presence of bacterial endotoxins in the blood, has been proposed as a mechanism linking high-sugar, low-fiber diets to systemic inflammation.

Oxidative stress. High blood glucose produces reactive oxygen species (ROS) that damage cells and trigger inflammation. This is the mechanism behind much of the tissue damage in diabetes, elevated blood glucose creates an environment of chronic oxidative stress that damages blood vessels, nerves, and kidneys.

Research Evidence

A 2015 study in American Journal of Clinical Nutrition found that consuming 40g of added sugar daily from sweetened beverages for 3 weeks elevated several inflammatory markers, including CRP, uric acid, and triglycerides, in healthy young men. The effect was specific to sugar-sweetened beverages versus diet beverages.

A 2017 study in Circulation found a dose-response relationship between sweetened beverage consumption and inflammatory biomarkers in a cohort of 3,000 women. Women who consumed more than 2 servings per day had 73% higher CRP levels than those who consumed less than 1 per month.

Meta-analyses of dietary interventions consistently find that low-sugar, low-glycemic diets reduce circulating CRP and other inflammatory markers, with effects visible within weeks.

The Western Diet Pattern

Individual nutrients are rarely eaten in isolation, and the inflammatory effects of sugar don’t exist separately from the overall dietary pattern. The “Western diet” — high in refined carbohydrates, added sugar, saturated fat, and sodium; low in fiber, omega-3 fatty acids, and micronutrients, is pro-inflammatory as a pattern. Components of the diet amplify or modulate each other’s effects.

Omega-3 fatty acids (from fatty fish, flaxseed, walnuts) actively suppress inflammatory signaling by competing with omega-6 fatty acids for the same enzymes. People consuming high amounts of added sugar but also high amounts of omega-3s show attenuated inflammatory responses compared to those consuming high sugar alone.

Dietary fiber feeds gut bacteria that produce short-chain fatty acids (acetate, propionate, butyrate), which have anti-inflammatory effects on the gut lining and, through circulation, on systemic inflammation. The near-total absence of fiber in highly processed food removes this protective mechanism.

Connection to Chronic Disease

Chronically elevated CRP and IL-6 are among the most reliable predictors of cardiovascular events, independent of traditional risk factors like blood pressure and cholesterol. The inflammatory pathway connecting high sugar intake to heart disease is a major proposed mechanism for the association documented in the 2014 Yang et al. JAMA Internal Medicine study.

In Alzheimer’s disease, neuroinflammation, characterized by activated microglia and elevated brain cytokines, is a consistent pathological finding. AGEs accumulate in the brains of Alzheimer’s patients, and cognitive decline is associated with elevated blood glucose and insulin resistance.

Chronic inflammation in adipose tissue is now understood to mediate much of the metabolic harm associated with obesity: visceral fat cells produce pro-inflammatory cytokines including TNF-α and IL-6, which drive systemic insulin resistance.

Sugar and Inflammation: Key Numbers

  • CRP above 3 mg/L: elevated cardiovascular risk
  • 40g daily added sugar from beverages: elevated CRP in 3 weeks (2015 study)
  • 2+ sweetened beverages/day vs. <1/month: 73% higher CRP in women
  • HbA1c above 6.5%: diagnostic for diabetes (reflects chronic elevated blood glucose/glycation)

See Also

Where to Read More